Among the anaplastic thyroid cancers, we saw three profound responses out of 10 patients, a relatively small exploratory cohort." Aplastic thyroid cancer is one of the most aggressive cancers that you can get, with a median survival of roughly four months and no cure rate. To have such a high rate of responses was shocking.
While the immunotherapy was not effective for all types of thyroid cancers, the response among anaplastic thyroid carcinoma patients merits further study, Lorch said.
This has already sparked a number of developments already. It has the potential to become important in the treatment of aggressive types of cancer.
In the study, 49 patients with different types of aggressive thyroid cancers were given the drugs every two weeks for a maximum of two years.
Collection
[
|
...
]